cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Regenxbio Inc
3 own
3 watching
Current Price
$18.2
$-0.06
(-0.33%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
791.06M
52-Week High
52-Week High
35.73
52-Week Low
52-Week Low
17.03
Average Volume
Average Volume
0.35M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
44.65
iconMarket Capitalization791.06M
icon52-Week High35.73
icon52-Week Low17.03
iconAverage Volume0.35M
iconDividend Yield--
iconP/E Ratio44.65
What does the Regenxbio Inc do?
Developing gene therapies for rare diseases with a proprietary delivery platform.
Read More
How much money does Regenxbio Inc make?
News & Events about Regenxbio Inc.
Market News Video
2 months ago
In trading on Wednesday, shares of REGENXBIO Inc (RGNX) crossed above their 200 day moving average of 24.76, changing hands as high as 25.27 per share. REGENXBIO Inc shares are currently trading up about 13.6% on the day...
PR Newswire
3 months ago
Additional Positive Interim Data from Phase I/II Trial of REGENXBIO'S RGX-111 for the Treatment of Severe MPS I Presented at WORLDSymposium Additional Positive Interim Data from Phase I/II Trial of REGENXBIO'S RGX-111 for the Treatment of Severe MPS I Presented at WORLDSymposium PR Newswire...
PR Newswire
3 months ago
REGENXBIO Announces Presentations at the 19th Annual WORLDSymposium 2023 REGENXBIO Announces Presentations at the 19th Annual WORLDSymposium 2023 PR Newswire ROCKVILLE, Md., Feb. 17, 2023 New interim data from Phase I/I/III trial of RGX-121 for the treatment of MPS II and Phase I/II trial of...
PR Newswire
3 months ago
REGENXBIO Presents Interim Data from Phase II Bridging Study Evaluating the Clinical Performance of RGX-314 Using the NAVXpress Manufacturing Platform Process REGENXBIO Presents Interim Data from Phase II Bridging Study Evaluating the Clinical Performance of RGX-314 Using the NAVXpress...
PR Newswire
3 months ago
REGENXBIO Announces Presentations at the Angiogenesis, Exudation, and Degeneration 2023 Conference REGENXBIO Announces Presentations at the Angiogenesis, Exudation, and Degeneration 2023 Conference PR Newswire ROCKVILLE, Md., Feb. 6, 2023 ROCKVILLE, Md., Feb. 6, 2023 /PRNewswire/ -- REGENXBIO Inc...
Frequently Asked Questions
Frequently Asked Questions
What is Regenxbio Inc share price today?
plus_minus_icon
Can Indians buy Regenxbio Inc shares?
plus_minus_icon
How can I buy Regenxbio Inc shares from India?
plus_minus_icon
Can Fractional shares of Regenxbio Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Regenxbio Inc stocks?
plus_minus_icon
What is today’s traded volume of Regenxbio Inc?
plus_minus_icon
What is today’s market capitalisation of Regenxbio Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Regenxbio Inc?
plus_minus_icon
What percentage is Regenxbio Inc down from its 52-Week High?
plus_minus_icon
What percentage is Regenxbio Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$18.2
$-0.06
(-0.33%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc.
$12.05
$0.11 (0.92 %)
Kura Oncology Inc
Kura Oncology Inc
$13.35
$-0.50 (-3.61 %)
Vericel Corporation
Vericel Corporation
$33.55
$0.48 (1.45 %)
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
$9.32
$0.36 (4.02 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc.
$12.05
$0.11 (0.92 %)
Kura Oncology Inc
Kura Oncology Inc
$13.35
$-0.50 (-3.61 %)
Vericel Corporation
Vericel Corporation
$33.55
$0.48 (1.45 %)
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
$9.32
$0.36 (4.02 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00